Centers for Disease Control and Prevention (CDC) provisional data on drug fatalities for year ending December 2024 indicates that the 2025 national goal of reducing drug fatalities to 81,000 or fewer was met one year early. We estimate the 2024 public health impacts of meeting that goal and analyze the impacts of three scenarios for 2025: continued downward trajectory of drug fatalities, stagnation, or regression of progress.

CDC 2024 data was compared to 2023 data to estimate lives saved, years of life saved, and valuation of statistical lives saved. Three scenarios for year ending December 2025 were compared to 2024 data to estimate the impact on the same metrics.

Drug fatality progress in 2024 relative to 2023 resulted in 29,646 lives saved, 928,916 years of life saved, and valuation of statistical lives saved ranging from $180 billion to $584 billion. If similar percentage declines in drug fatalities occur in 2025, another 21,659 lives would be saved. However, if drug fatalities flatten or rise in 2025, opportunities to save lives be lost.

Meeting the national goal one year early resulted in substantial public health benefits in 2024. Now, programmatic and policy efforts must prevent stagnation or backsliding.